Vaccine production

PHARMAQ, an industry leader in the manufacturing and distribution of fish vaccines for aquaculture, is currently planning to relocate their viral antigen manufacturing facility.

Project challenges

io-consultants jointly developed a general concept with PHARMAQ for a new viral antigen facility with single-use process technology. Emphasis was on increasing process safety and minimizing investment cost by closed aseptic processing. The outcome is a flexible, modular building concept with optimized personnel and material flow. Also io-consultants was supporting PHARMAQ in their site selection process for the new facility.

Task: 
General concept with for new viral antigen facility with single-use process technology

Services:
Pharma/Biotech planning

Location:
Oslo, Norway

Customer value

The result was a flexible modular building concept with optimized personal and material flow. Currently the project is in the basic design phase.

Please contact us 

Ansprechpartner Pharma Biotech: Dr. Gregor Dudziak
Dr. Gregor Dudziak Member of the Management Board/Partner Phone: +49 (0) 62 21 / 379-111